Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 5
2004 1
2005 5
2006 11
2007 5
2008 8
2009 1
2010 2
2011 3
2012 2
2013 3
2014 1
2015 1
2016 2
2017 4
2018 3
2019 6
2020 5
2021 5
2022 2
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Epigenetic therapies of osteoporosis.
de Nigris F, Ruosi C, Colella G, Napoli C. de Nigris F, et al. Bone. 2021 Jan;142:115680. doi: 10.1016/j.bone.2020.115680. Epub 2020 Oct 6. Bone. 2021. PMID: 33031975 Review.
Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead.
Colao A, de Nigris F, Modica R, Napoli C. Colao A, et al. Among authors: de nigris f. Front Endocrinol (Lausanne). 2020 Dec 15;11:604341. doi: 10.3389/fendo.2020.604341. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33384663 Free PMC article. Review.
Involvement of Mediator complex in malignancy.
Schiano C, Casamassimi A, Rienzo M, de Nigris F, Sommese L, Napoli C. Schiano C, et al. Among authors: de nigris f. Biochim Biophys Acta. 2014 Jan;1845(1):66-83. doi: 10.1016/j.bbcan.2013.12.001. Epub 2013 Dec 14. Biochim Biophys Acta. 2014. PMID: 24342527 Review.
Yin Yang I as an Epimodulator of miRNAs in the Metastatic Cascade.
Ruosi C, Colella G, Fazioli F, Miceli R, Gallo M, Di Salvatore MG, Cimmino A, de Nigris F. Ruosi C, et al. Among authors: de nigris f. Crit Rev Oncog. 2017;22(1-2):99-107. doi: 10.1615/CritRevOncog.2017020855. Crit Rev Oncog. 2017. PMID: 29604939 Review.
CXCR4 inhibitors: tumor vasculature and therapeutic challenges.
de Nigris F, Schiano C, Infante T, Napoli C. de Nigris F, et al. Recent Pat Anticancer Drug Discov. 2012 Sep;7(3):251-64. doi: 10.2174/157489212801820039. Recent Pat Anticancer Drug Discov. 2012. PMID: 22376154 Review.
79 results